You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Aspiro Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ASPIRO, and what generic and branded alternatives to ASPIRO drugs are available?

ASPIRO has eighteen approved drugs.

Summary for Aspiro

US Patents:	0
Tradenames:	16
Ingredients:	16
NDAs:	18

Drugs and US Patents for Aspiro

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aspiro	OLANZAPINE	olanzapine	INJECTABLE;INTRAMUSCULAR	217466-001	Mar 22, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Aspiro	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	216591-001	Jul 6, 2022	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Aspiro	KETOROLAC TROMETHAMINE	ketorolac tromethamine	INJECTABLE;INJECTION	217166-001	Jun 20, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Aspiro	ACETAMINOPHEN	acetaminophen	SOLUTION;INTRAVENOUS	216617-001	Jul 27, 2022	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Aspiro	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	216591-002	Jul 6, 2022	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Aspiro	SUGAMMADEX SODIUM	sugammadex sodium	SOLUTION;INTRAVENOUS	214337-001	Jun 9, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Aspiro	DAPTOMYCIN	daptomycin	POWDER;INTRAVENOUS	216445-001	Dec 23, 2022	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Aspiro

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.